3D Cell Cultures: Products, Technologies and Key Application Areas (2nd Edition), 2017-2030
Thursday, October 12, 2017
LONDON, Oct. 12, 2017 /PRNewswire/ --
A number of research efforts in drug discovery are being directed towards the introduction of in vitro testing models that replicate the in vivo microenvironment and provide physiologically relevant insights. Cell culture monolayers or 2D cell cultures are known to harbor differences in morphology, growth rate, function, viability and the overall behavior, as compared to those in natural environment.
Download the full report: https://www.reportbuyer.com/product/5139479
However, it has been realized that 3D cell cultures facilitate cell interaction with the surrounding media in all the possible dimensions. Cells cultivated using 3D techniques provide an appropriate ecosystem for cells to grow and proliferate and, consequently generate more accurate results of the experiments conducted on them.
The 3D cell culture industry is currently characterized by presence of several scaffold-based and scaffold-free products and services, widely being used for the purpose of research across a variety of application areas. Examples of scaffold-based 3D culture products include solid scaffolds, hydrogels, ECM-coated plates and microcarriers.
Products, such as hanging drop plates, ultra-low attachment surfaces, micropatterned plates and suspension culture systems (such as 3D bioreactors), are some of the important scaffold-free 3D technologies that are currently available. It is worth highlighting that despite the advantages that they offer, the adoption of 3D cell cultures is hindered by certain challenges.
These cell culture systems are currently limited to small scale production of cells, thereby, restricting their use to research applications only. Moreover, 3D culture techniques still need to be optimized in order to ensure consistency of results generated across different scales of operation. Due to the aforementioned challenges, 2D cultures continue to be preferred over 3D culture systems; however, with increasing awareness of the advantages of 3D cultures, a significant proportion of researchers are anticipated to gradually transition towards 3D culture systems.
SCOPE OF THE REPORT
It is well-known that, of the several drug / therapy candidates undergoing clinical evaluation, very few make it to advanced stages and an even lesser number receive regulatory approval. One of the key reasons for the failure of therapeutic candidates in clinical trials is the use of conventional 2D cell culture systems in early research studies. It is important to reiterate that these 2D systems are severely limited in a number of aspects. For instance, only 50% of the cell surface is exposed to the culture media; as a result, the actual responses of cells to specific modulators / stimulants cannot be accurately understood.
It is also worth noting that attrition rates of close to 95% have been reported for anti-cancer drug candidates as a result of inaccurate in vitro drug efficacy results and unforeseen toxicity issues that were not properly assessed due to the limitation of 2D culture models. The use of advanced 3D cell culture techniques in in vitro studies is seen to have the capability to overcome several such challenges, currently associated with 2D systems.
The '3D Cell Cultures: Products, Technologies and Key Application Areas (2nd Edition), 2017-2030' report features an extensive study on the various scaffold-based and scaffold-free 3D culture systems. We identified over 80 hydrogel / ECM based products, 70 inserts / plates / other cultureware and 50 3D bioreactors that are widely being used for a variety of research applications across the globe. In addition, several kits, assays and tools are also available to carry out cytotoxicity assessments, transfections and cell viability testing.
Amongst other elements, the report features:
-- An elaborate discussion on the methods used for fabrication of 3D scaffolds and matrices, highlighting the materials used, the process of fabrication, merits and demerits, and the applications of all of the methods.
-- An in-depth classification of 3D culture systems, which are categorized under scaffold-based systems (such as hydrogels / ECMs, solid scaffolds, micropatterned surfaces and microcarriers) and scaffold-free (such as hanging drop plates, suspension culture systems and organ-on-chips) 3D culture systems.
-- A review of the overall landscape of the 3D cell culture market with respect to scaffold-format (scaffold-based / scaffold-free), product type (Hydrogels / ECMs, 3D cultureware, 3D bioreactors), product sub-type (hydrogels / ECMs are further classified on the basis of source and 3D cultureware on the basis of solid scaffolds, suspension culture systems, microfluidic systems, ECM-coated plates, attachment resistant cell culture plates, micropatterned surfaces) and product availability across different regions of the world.
-- Comprehensive profiles of the key developers (with two or more unique bioreactors in their portfolio) of 3D bioreactors, featuring a brief company overview, description of the product, advantages, applications, collaborations related to the product, and a comprehensive future outlook. Additionally, the report includes profiles of companies with more than five unique 3D culture products (inserts or plates or hydrogels) in their portfolio and those that specialize in the field of organ-on-chips.
-- A social media analysis depicting the prevalent and emerging trends, and the popularity of 3D cell cultures on the social media platform, Twitter. The analysis was carried out using tweets posted on the platform from 2008 to 2017.
-- An insightful analysis, highlighting the applications of each of the 3D culture products mentioned in the market landscape. The applications have been categorized under [A] Cancer research, [B] Drug discovery and toxicity screening, [C] Stem cell research, [D] Tissue engineering / regenerative medicine. Additionally, the section represents the distribution of each of the product segments across the aforementioned applications, highlighting the relevance of different types of products in biomedical research.
One of the key objectives of the report was to estimate the future size of the global 3D cell culture market. We adopted a top-down approach to evaluate the likely success and the growth of the market over the next 10-15 years. The insights generated on the future opportunity are segmented on the basis of applications areas, key geographies (the US, EU, Asia and the rest of the world), product type, scaffold format (scaffold-based versus scaffold-free) and the end use (research versus therapeutics). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios for the period 2017-2030, namely conservative, base and optimistic scenarios, which represent three different tracks of the industry's evolution.
The research, analysis and insights presented in this report are backed by a deep understanding of key insights gathered from both secondary and primary research. The report presents details of the conversations with (in alphabetical order of company name) Scott Brush (VP Sales and Marketing, BRTI Life Sciences), Jens Kelm (CSO, InSphero), Darlene Thieken (Project Manager, Nanofiber Solutions), Colin Sanctuary (Co-Founder and CEO, QGel), Bill Anderson (President / CEO, Synthecon), Anonymous (President and CEO, US based start-up), Anonymous (VP Technical, Business Operations & Co-Founder, US based company).
The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews with experts in the area (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Where possible, the available data has been checked for accuracy from multiple sources of information.
The secondary sources of information include
-- Annual reports
-- Investor presentations
-- SEC filings
-- Industry databases
-- News releases from company websites
-- Government policy documents
-- Industry analysts' views
While the focus has been on forecasting the market over the coming 10-15 years, the report also provides our independent view on various technological and non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.
Chapter 2 presents an executive summary of the report. It offers a high-level view on where the 3D cell cultures market is headed in the mid to long term.
Chapter 3 provides a general introduction to 3D culture systems. In this section, we have briefly discussed the different types of cell cultures, the various methods of cell culturing and their application areas. The chapter features a comparative analysis of 2D and 3D cultures, and highlights the current need and advantages of 3D culture systems.
Chapter 4 gives an overview of the classification of 3D culture systems. It highlights the different 3D culture technologies, classified under scaffold-based and scaffold-free systems. It also highlights, in detail, the underlying concepts, advantages and disadvantages of each sub-category of 3D systems.
Chapter 5 presents summaries of the different techniques that are utilized to fabricate various 3D scaffolds and matrices. It provides information on the working principle, and merits and demerits associated with these methods. It also presents the key takeaways from various research studies that were carried out on matrices fabricated using the aforementioned methods.
Chapter 6 provides comprehensive lists of the different 3D culture systems that are available in the market or are under development. The section also presents analyses of the products on the basis of scaffold type, product type (3D hydrogels and ECMs / 3D cultureware / 3D bioreactors) and product sub-type. In addition, the chapter provides information on the geographical presence of the developers of these 3D culture systems and details on the companies that offer 3D culture related services and associated consumables.
Chapter 7 presents a detailed overview on the most popular application areas, which include cancer research, drug discovery and toxicity screening, stem cell research and tissue engineering / regenerative medicine. It features an elaborate analysis, highlighting the application area(s) for all the products mentioned in the market landscape (Chapter 6). Additionally, the section features an illustrative representation of the product type(s) that are most widely used for a particular application.
Chapter 8 provides insights on the popularity of 3D cell cultures on the social media platform, Twitter. The section highlights the yearly distribution of tweets posted on the platform in the time period 2008-2017, and the most significant events responsible for increase / decrease in the volume of tweets each year, during the above-mentioned time period. Additionally, the chapter showcases the most talked about 3D culture products and application areas on social media.
Chapter 9 provides detailed profiles of the players with over five unique products in their 3D culture portfolio (hydrogels / ECMs and 3D cultureware). Each profile includes information on the developer, its product portfolio, recent collaborations and a discussion on the future outlook of the company. Additionally, the chapter includes profiles of prominent developers of organ-on-chips.
Chapter 10 presents detailed profiles of key players with more than two unique 3D bioreactors in their portfolio. Each profile includes a brief overview of the developer, information on the product portfolio and a discussion on the future outlook of the company.
Chapter 11 presents a comprehensive market forecast, highlighting the future potential of the market till 2030. The chapter presents a detailed market segmentation on the basis of product type (3D bioreactors, hydrogels / ECM, solid scaffolds, microfluidic plates, suspension culture systems), scaffold type (scaffold-based versus scaffold-free) and end use (research versus therapeutics) that are likely to contribute to the market in the coming decade. Additionally, the section highlights the contribution of different geographies (the North America, EU, Asia and rest of the world) in the 3D culture market.
Chapter 12 presents insights from the survey conducted for this study. We invited close to 100 stakeholders involved in the development of 3D cell culture systems. The participants, who were primarily Founder / CXO / Senior Management level representatives of their respective companies, helped us develop a deeper understanding on the nature of their services and the associated commercial potential.
Chapter 13 summarizes the overall report. The chapter provides a list of the key takeaways and presents our independent opinion on the 3D cell cultures market, based on the research and analysis described in the previous chapters.
Chapter 14 is a collection of interview transcripts of the discussions held with key stakeholders in this market. In this chapter, we have presented the details of our conversations with (in alphabetical order of company name) Scott Brush (VP Sales and Marketing, BRTI Life Sciences), Jens Kelm (CSO, InSphero), Darlene Thieken (Project Manager, Nanofiber Solutions), Colin Sanctuary (Co-Founder and CEO, QGel), Bill Anderson (President / CEO, Synthecon), Anonymous (President and CEO, US based start-up), Anonymous (VP Technical, Business Operations & Co-Founder, US based company).
Chapter 15 is an appendix, which provides tabulated data and numbers for all the figures included in the report.
Chapter 16 is an appendix, which provides the list of companies and organizations mentioned in the report.
1. Over 200 3D cell culture products are either commercially available or are under development; of these, ~60% use scaffold based while ~40% use scaffold free formats. Some products can be used as both scaffold based and scaffold free formats. Of the total number of 3D cell culture products, 40% are hydrogels / ECMs and 34% are 3D cultureware products. In addition to the aforementioned products, the 3D cell culture market includes several 3D bioreactors, which have emerged as important scaffold free systems to carry out large scale production.
2. The market is characterized by the presence of nearly 125 players; in addition to industry stalwarts, the landscape features participation of several small-sized and mid-sized firms. Examples of small-sized companies that offer 3D culture products include (in alphabetical order) 3D BioMatrix, Celartia, Cellec Biotek, EBERS, Global Cell Solutions, Nanofiber Solutions, Nano3D Biosciences, PBS Biotech and RealBio Technology. Some of the mid-sized players that are active in this area include (in alphabetical order) 4titude®, Koken, MatTek Corporation, STEMCELL Technologies and TAP Biosystems. Examples of the established players include (in alphabetical order) Corning Life Sciences, EMD Millipore, GE Healthcare, Sigma-Aldrich and Thermo Fisher Scientific.
3. An analysis on the social media platform, Twitter, reveals an increasing volume of tweets related to the 3D cell cultures; between 2008 and 2016, a CAGR of 57% was registered in the number of tweets. In the given time period, over 4000 relevant tweets were recorded; this clearly indicates an upsurge in the popularity of the 3D cell culture approaches.
4. Over 90% of the overall 3D cell culture market is focused on research. However, as the challenges (such as lack of awareness, constraints in scalability and inconsistencies in system optimization) associated with the application of these robust culture systems are addressed, these systems are expected to be extensively used for the development, manufacturing and characterization of pharmacological interventions.
5. Our outlook is highly promising as we anticipate the use of 3D cell culture systems across different application areas over the coming decade. In fact, we predict the market to grow at an annualized rate of over 20% till 2030. From a regional perspective, North America (specifically the US) is likely to maintain its domination in the future.
6. Cancer research and drug discovery, with over 50% share, currently account for a significant portion of the market. As the research pace heightens, the use of 3D cell cultures in stem cell research and tissue engineering / regenerative medicine, currently representing a sizeable share, is also likely to expand aggressively.
Download the full report: https://www.reportbuyer.com/product/5139479
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48
View original content:http://www.prnewswire.com/news-releases/3d-cell-cultures-products-technologies-and-key-application-areas-2nd-edition-2017-2030-300535979.html
||Cloud Foundry Closes 2017 With Substantial Project Growth & Membership Support | Dec 14, 2017
||Jewelers of America Releases 2017 Fine Jewelry Industry Consumer and Retail Market Study | Dec 14, 2017
||Conqueror's Blade Beta Access - Coming Soon to PC | Dec 14, 2017
||Edmunds Announces Partnership with Consumer Technology Association to Produce New Vehicle Tech Awards Program at CES | Dec 14, 2017
||Tandem Theory Designs Develops and Launches Three New Websites for Del Frisco's Restaurant Group | Dec 14, 2017
||Morning Technical Insight on These Printed Circuit Boards Stocks -- Flex, TTM Technologies, Jabil, and Celestica | Dec 14, 2017
||Mobility Is Medicine: Healthcare Professionals Around The Country Join New Online Platform By The Hundreds | Dec 14, 2017
||The Nuttery Joins Forces With Meow Wolf on Galaga Chronicles | Dec 14, 2017
||G-SHOCK Announces New Colorways For Street Style Watches Ahead Of Holiday Season | Dec 14, 2017
||MadHive(TM) and the Mad Foundation Announce MADtoken Sale to Create Open Blockchain Network for Ad Industry | Dec 14, 2017